Malaria vaccine (FMP012) - Walter Reed Army Institute of Research/US Army Medical Research and Materiel Command

Drug Profile

Malaria vaccine (FMP012) - Walter Reed Army Institute of Research/US Army Medical Research and Materiel Command

Alternative Names: Falciparum malaria protein-12 vaccine; FMP012; FMP012 subunit malaria vaccine - WRAIR; FMP012/AS01B malaria vaccine; Malaria vaccine PfCelTOS WRAIR; Malaria vaccine recombinant FMP012; Plasmodium falciparum FMP012 vaccine; Plasmodium falciparum PfCelTOS vaccine; Plasmodium falciparum vaccine FMP012; Recombinant FMP012 malaria vaccine

Latest Information Update: 28 Jul 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator United States Army Medical Research and Materiel Command; Walter Reed Army Institute of Research
  • Class Antimalarials; Parasitic vaccines; Subunit vaccines; Synthetic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Malaria

Most Recent Events

  • 28 Jul 2018 No recent reports of development identified for phase-I development in Malaria(Prevention, In volunteers) in USA (IM, Injection)
  • 11 Jun 2014 Preclinical trials in Malaria (Prevention) in USA (IM)
  • 11 Jun 2014 Walter Reed Army Institute of Research and US Army Medical Research and Materiel Command plan a phase I trial for Malaria (Prevention) in USA (NCT02174978)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top